Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
J Virol ; 88(8): 4466-79, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24501407

RESUMO

UNLABELLED: Periodontal pathogens such as Porphyromonas gingivalis and Fusobacterium nucleatum produce five different short-chain fatty acids (SCFAs) as metabolic by-products. We detect significantly higher levels of SCFAs in the saliva of patients with severe periodontal disease. The different SCFAs stimulate lytic gene expression of Kaposi's sarcoma-associated herpesvirus (KSHV) dose dependently and synergistically. SCFAs inhibit class-1/2 histone deacetylases (HDACs) and downregulate expression of silent information regulator-1 (SIRT1). SCFAs also downregulate expression of enhancer of zeste homolog2 (EZH2) and suppressor of variegation 3-9 homolog1 (SUV39H1), which are two histone N-lysine methyltransferases (HLMTs). By suppressing the different components of host epigenetic regulatory machinery, SCFAs increase histone acetylation and decrease repressive histone trimethylations to transactivate the viral chromatin. These new findings provide mechanistic support that SCFAs from periodontal pathogens stimulate KSHV replication and infection in the oral cavity and are potential risk factors for development of oral Kaposi's sarcoma (KS). IMPORTANCE: About 20% of KS patients develop KS lesions first in the oral cavity, while other patients never develop oral KS. It is not known if the oral microenvironment plays a role in oral KS tumor development. In this work, we demonstrate that a group of metabolic by-products, namely, short-chain fatty acids, from bacteria that cause periodontal disease promote lytic replication of KSHV, the etiological agent associated with KS. These new findings provide mechanistic support that periodontal pathogens create a unique microenvironment in the oral cavity that contributes to KSHV replication and development of oral KS.


Assuntos
Coinfecção/microbiologia , Coinfecção/virologia , Ácidos Graxos Voláteis/metabolismo , Herpesvirus Humano 8/fisiologia , Metiltransferases/genética , Complexo Repressor Polycomb 2/genética , Proteínas Repressoras/genética , Sarcoma de Kaposi/enzimologia , Replicação Viral , Adulto , Idoso , Coinfecção/enzimologia , Coinfecção/metabolismo , Regulação para Baixo , Proteína Potenciadora do Homólogo 2 de Zeste , Feminino , Fusobacterium nucleatum/metabolismo , Herpesvirus Humano 8/genética , Humanos , Masculino , Metiltransferases/metabolismo , Pessoa de Meia-Idade , Doenças Periodontais/microbiologia , Complexo Repressor Polycomb 2/metabolismo , Porphyromonas gingivalis/metabolismo , Proteínas Repressoras/metabolismo , Sarcoma de Kaposi/genética , Sarcoma de Kaposi/metabolismo , Sarcoma de Kaposi/virologia
2.
Epigenetics ; 8(7): 703-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23804146

RESUMO

HIV-infected subjects on highly active antiretroviral therapy (HAART) are susceptible to comorbid microbial infections in the oral cavity. We observed that primary oral epithelial cells (POECs) isolated from HIV+ subjects on HAART grow more slowly and are less innate immune responsive to microbial challenge when compared with POECs from normal subjects. These aberrant cells also demonstrate epigenetic differences that include reduction in histone deacetylase 1 (HDAC-1) levels and reduced total DNA methyltransferase (DNMT) activity specific to enzymes DNMT1 and DNMT3A. The DNMT activity correlates well with global DNA methylation, indicating that aberrant DNMT activity in HIV+ (on HAART) POECs leads to an aberrantly methylated epithelial cell phenotype. Overall, our results lead us to hypothesize that, in patients with chronic HIV infection on HAART, epigenetic changes in key genes result in increased vulnerability to microbial infection in the oral cavity.


Assuntos
Terapia Antirretroviral de Alta Atividade , Epigênese Genética , Células Epiteliais/metabolismo , Soropositividade para HIV/genética , Soropositividade para HIV/virologia , Boca/patologia , Proliferação de Células , Separação Celular , Parede Celular/química , DNA (Citosina-5-)-Metiltransferase 1 , DNA (Citosina-5-)-Metiltransferases/metabolismo , Metilação de DNA/genética , Células Epiteliais/patologia , Células Epiteliais/virologia , Fusobacterium nucleatum/metabolismo , Soropositividade para HIV/tratamento farmacológico , Humanos , Boca/metabolismo , Boca/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA